Novel regulations of the angiotensin II receptor type 1 by calmodulin

被引:6
|
作者
Ehlers, Kevin [1 ]
Clements, Robert [1 ]
VerMeer, Mark [1 ]
Giles, Jennifer [1 ]
Tran, Quang-Kim [1 ]
机构
[1] Des Moines Univ, Osteopath Med Ctr, Dept Physiol & Pharmacol, 3200 Grand Ave,Ryan Hall 258, Des Moines, IA 50312 USA
基金
美国国家卫生研究院;
关键词
Angiotensin II receptor type 1; Calmodulin; Calcium; FRET biosensor; Angiotensin II; SMOOTH-MUSCLE-CELLS; PLASMA-MEMBRANE; BINDING; PROTEINS; NETWORK; PHOSPHORYLATION; INTERACTS; DOMAINS; SYSTEM; KINASE;
D O I
10.1016/j.bcp.2018.03.027
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The angiotensin II receptor type 1 (AT(1)R) mediates many Ca2+-dependent actions of angiotensin II (AngII). Calmodulin (CaM) is a key transducer of Ca2+ signals in cells. Two locations on the receptor's submembrane domains (SMD) 3 and 4 are known to interact with CaM. However, the binding sites for CaM, biochemical properties of the interactions, and their functional impact are not fully understood. Using a FRET-based screening method, we identified a new binding site for CaM on SMD2 (a.a. 125-141), in addition to SMD3 and the juxtamembranous region of SMD4 (SMD4(JM), a.a., 309-327). Simultaneous measurements of CaM binding and free Ca2+ show that the interactions are Ca2+-dependent, with disparate K-d and EC50(Ca2+) values within the physiological range of cytoplasmic Ca2+. Full interaction between CaM and SMD3 requires the entire domain (a.a. 215-242) and has an EC50(Ca2+) value in the range of resting cytoplasmic Ca2+, suggesting AT(1)R-CaM interaction can occur in resting conditions in cells. AngII induces robust ERK1/2 phosphorylation in primary vascular smooth muscle cells. This effect is suppressed by AT(1)R inhibitor losartan and virtually abolished by CaM antagonist W-7. AngII-induced ERK1/2 phosphorylation is suppressed in cells expressing mutant AT(1)R with reduced CaM binding at each identified binding domain. AngII triggers transient Ca2+ signals in cells expressing wild-type AT(1)R. These signals are reduced in cells expressing mutant AT(1)R with reduced CaM binding at SMD3 or SMD4(JM), but are very slow-rising, low amplitude signal in cells expressing AT(1)R. with reduced CaM binding at SMD2. The data indicate that CaM interactions with AT(1)R can occur at various domains, with different affinities, at different physiological Ca2+ levels, and are important for AT(1)R-mediated signaling.
引用
收藏
页码:187 / 200
页数:14
相关论文
共 50 条
  • [21] Angiotensin II Type 1 Receptor Autoantibody Prolonged Angiotensin II Type 1 Receptor Activation Through Attenuating Receptor Internalization in Cultured Vascular Smooth Muscle Cells
    Lei, Jinghui
    Zhang, Suli
    Bian, Jingwei
    Yin, Xiaochen
    Wang, Peng
    Wang, Pengli
    Wu, Ye
    Liu, Huirong
    CIRCULATION, 2016, 134
  • [22] Assessing the Relationship of Angiotensin II Type 1 Receptors with Erythropoietin in a Human Model of Endogenous Angiotensin II Type 1 Receptor Antagonism
    Calo, Lorenzo A.
    Davis, Paul A.
    Maiolino, Giuseppe
    Pagnin, Elisa
    Ravarotto, Verdiana
    Naso, Elena
    Carraro, Gianni
    Naso, Agostino
    CARDIORENAL MEDICINE, 2016, 6 (01) : 16 - 24
  • [23] Therapeutic targets in the brain for overactive bladder: A focus on angiotensin II type 1 receptor
    Shimizu, Shogo
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2023, 153 (02) : 69 - 72
  • [24] Involvement of angiotensin II type 1 receptor on pathological remodeling and dysfunction in obstructed bladder
    Aikawa, Ken
    Sakai, Takio
    Ishibashi, Kei
    Shiomi, Homare
    Sagawa, Koji
    Kumagai, Shin
    Kataoka, Masao
    Akaihata, Hidenori
    Yamaguchi, Osamu
    INTERNATIONAL JOURNAL OF UROLOGY, 2012, 19 (05) : 457 - 464
  • [25] Angiopoietin-like protein 2 expression is suppressed by angiotensin II via the angiotensin II type 1 receptor in rat cardiomyocytes
    Wang, Shuya
    Li, Ying
    Miao, Wei
    Zhao, Hong
    Zhang, Feng
    Liu, Nan
    Su, Guohai
    Cai, Xiaojun
    MOLECULAR MEDICINE REPORTS, 2016, 14 (03) : 2607 - 2613
  • [26] Angiotensin II type 2 receptor gene transfer downregulates angiotensin II type 1a receptor in vascular smooth muscle cells
    Jin, XQ
    Fukuda, N
    Su, JZ
    Lai, YM
    Suzuki, R
    Tahira, Y
    Takagi, H
    Ikeda, Y
    Kanmatsuse, K
    Miyazaki, H
    HYPERTENSION, 2002, 39 (05) : 1021 - 1027
  • [27] The Angiotensin II type 2 receptor causes constitutive growth of cardiomyocytes and does not antagonize angiotensin II type 1 receptor - Mediated hypertrophy
    D'Amore, A
    Black, MJ
    Thomas, WG
    HYPERTENSION, 2005, 46 (06) : 1347 - 1354
  • [28] DanHong injection targets endothelin receptor type B and angiotensin II receptor type 1 in protection against cardiac hypertrophy
    Zhang, Min-Yu
    Guo, Fei-Fei
    Wu, Hong-Wei
    Yu, Yang-Yang
    Wei, Jun-Ying
    Wang, Shi-Feng
    Zhang, Yu-Xin
    Xian, Ming-Hua
    Wu, Qing-Hua
    Zhao, Bu-Chang
    Li, Shi-You
    Yang, Hong-Jun
    ONCOTARGET, 2017, 8 (61) : 103393 - 103409
  • [29] Importance of tyrosine phosphorylation in angiotensin II type 1 receptor signaling
    Schieffer, B
    Paxton, WG
    Marrero, MB
    Bernstein, KE
    HYPERTENSION, 1996, 27 (03) : 476 - 480
  • [30] Inhibition of the angiotensin II type 2 receptor AT2R is a novel therapeutic strategy for glioblastoma
    Perryman, Richard
    Renziehausen, Alexander
    Shaye, Hamidreza
    Kostagianni, Androniki D.
    Tsiailanis, Antonis D.
    Thorne, Thomas
    Chatziathanasiadou, Maria, V
    Sivolapenko, Gregory B.
    El Mubarak, Mohamed Ahmed
    Han, Gye Won
    Zarzycka, Barbara
    Katritch, Vsevolod
    Lebon, Guillaume
    Lo Nigro, Cristiana
    Lattanzio, Laura
    Morse, Sophie, V
    Choi, James J.
    O'Neill, Kevin
    Kanaki, Zoi
    Klinakis, Apostolos
    Crook, Tim
    Cherezov, Vadim
    Tzakos, Andreas G.
    Syed, Nelofer
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2022, 119 (32)